BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8004607)

  • 21. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does Progesterone Receptor Matter in the Risk of Recurrence for Patients With Ductal Carcinoma in Situ?
    Chaudhary LN; Jawa Z; Hanif A; Szabo A; Kamaraju S; Cheng YC; Chitambar CR
    WMJ; 2018 Jun; 117(2):62-67. PubMed ID: 30048574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ of the breast--current management.
    Sharma S; Hill AD; McDermott EW; O'Higgins NJ
    Eur J Surg Oncol; 1997 Jun; 23(3):191-7. PubMed ID: 9236888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
    Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
    AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing breast disease.
    Chapman B
    CAP Today; 1998 Jul; 12(7):74, 76, 80 passim. PubMed ID: 10181880
    [No Abstract]   [Full Text] [Related]  

  • 29. Ductal carcinoma in situ of the breast.
    Fonseca R; Hartmann LC; Petersen IA; Donohue JH; Crotty TB; Gisvold JJ
    Ann Intern Med; 1997 Dec; 127(11):1013-22. PubMed ID: 9412283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ductal carcinoma in situ of the breast in men: a review.
    Pappo I; Wasserman I; Halevy A
    Clin Breast Cancer; 2005 Oct; 6(4):310-4. PubMed ID: 16277880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductal carcinoma in situ of the breast: progress and controversy.
    Swallow CJ; Van Zee KJ; Sacchini V; Borgen PI
    Curr Probl Surg; 1996 Jul; 33(7):553-600. PubMed ID: 8765465
    [No Abstract]   [Full Text] [Related]  

  • 33. Common questions about ductal carcinoma in situ.
    Dell DD
    Am J Nurs; 1997 May; 97(5):61-3, 65-6. PubMed ID: 9155799
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast disease: a primer on diagnosis and management.
    Drukker BH
    Int J Fertil Womens Med; 1997; 42(5):278-87. PubMed ID: 9406832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ductal carcinoma in situ of the breast.
    Silverstein MJ
    Annu Rev Med; 2000; 51():17-32. PubMed ID: 10774450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic classification of breast ductal carcinoma-in-situ.
    Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
    Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ breast carcinoma.
    Frykberg ER; Bland KI
    Adv Surg; 1993; 26():29-72. PubMed ID: 8380307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases].
    Cutuli B; Lemanski C; Fourquet A; de Lafontan B; Giard S; Lancrenon S; Meunier A; Pioud-Martigny R; Campana F; Marsiglia H; Mery E; Penault-Llorca F; Fondrinier E; de Lara CT
    Bull Cancer; 2010 Mar; 97(3):301-10. PubMed ID: 20159677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ductal carcinoma in situ.
    Loring L; Dershaw DD
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.